Literature DB >> 15703979

Risk factors for pulmonary candidiasis in preterm infants with a birth weight of less than 1250 g.

Simonetta Frezza1, Luca Maggio, Maria Pia De Carolis, Francesca Gallini, Maria Puopolo, Valentina Polimeni, Simonetta Costa, Giovanni Vento, Giuseppe Tortorolo.   

Abstract

UNLABELLED: To evaluate the epidemiology of pulmonary candidiasis (PC) and to identify risk factors in premature infants during the 1st month of life, all infants with a birth weight <1250 g admitted to our neonatal intensive care unit with PC between January 1994 and December 2001 were retrospectively reviewed. Infants with PC ( n =20) were compared with a control group ( n =20), matched for gestational age and birth weight, with regard to possible perinatal and postnatal risk factors. Among 325 infants with a birth weight <1250 g, 20 out of 233 ventilated infants (8.6%) developed PC. Candida albicans ( n =12) and C. parapsilosis ( n =4) were the predominant isolates. Neonates with PC were significantly different from controls with regard to male prevalence ( P =0.002), rates of preterm premature rupture of membranes (PPROM) ( P =0.02), longer duration of antibiotic therapy ( P =0.01) and of ventilation ( P =0.02). The difference between groups did not attain significance with regard to postnatal dexamethasone administration, duration of central vein catheterisation and duration of parenteral nutrition. Multivariate logistic regression analysis indicated as significant predictors of PC, among perinatal data, the male gender (OR =26.3; 95%CI 2.44 to 284) and PPROM (OR =12.3; 95%CI 1.16 to 130) and, among postnatal data, the duration of ventilation (OR =1.54; 95%CI 1.01 to 2.34).
CONCLUSION: The presence of preterm premature rupture of membranes and the duration of ventilation are significant risk factors for developing pulmonary candidiasis and should be considered in the preventive efforts to reduce this disease in infants with a birth weight <1250 g.

Entities:  

Mesh:

Year:  2004        PMID: 15703979     DOI: 10.1007/s00431-004-1571-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Estimated early-onset group B streptococcal neonatal disease.

Authors:  Suzanne Luck; Michael Torny; Katrina d'Agapeyeff; Alison Pitt; Paul Heath; Aoadhan Breathnach; Alison Bedford Russell
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

Review 2.  Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options.

Authors:  Eugene Leibovitz
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

3.  When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.

Authors:  D K Benjamin; K Ross; R E McKinney; D K Benjamin; R Auten; R G Fisher
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

4.  Surveillance of ventilator-associated pneumonia in very-low-birth-weight infants.

Authors:  Leandro Cordero; Leona W Ayers; Randy R Miller; John H Seguin; Brian D Coley
Journal:  Am J Infect Control       Date:  2002-02       Impact factor: 2.918

5.  Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams.

Authors:  Angelina Pera; Angela Byun; Steven Gribar; Rama Schwartz; Deepak Kumar; Prabhu Parimi
Journal:  J Perinatol       Date:  2002 Apr-May       Impact factor: 2.521

6.  Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes.

Authors:  Anucha Apisarnthanarak; Galit Holzmann-Pazgal; Aaron Hamvas; Margaret A Olsen; Victoria J Fraser
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

7.  Association of fungal colonization and invasive disease in very low birth weight infants.

Authors:  Y C Huang; C C Li; T Y Lin; R I Lien; Y H Chou; J L Wu; C Hsueh
Journal:  Pediatr Infect Dis J       Date:  1998-09       Impact factor: 2.129

Review 8.  Candida infections in the neonate.

Authors:  Rachel L Chapman
Journal:  Curr Opin Pediatr       Date:  2003-02       Impact factor: 2.856

9.  Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.

Authors:  E H Kossoff; E S Buescher; M G Karlowicz
Journal:  Pediatr Infect Dis J       Date:  1998-06       Impact factor: 2.129

10.  Reduced lymphocyte-mediated antifungal capacity in high-risk infants.

Authors:  Linda Witek-Janusek; Maliha J Shareef; Herbert L Mathews
Journal:  J Infect Dis       Date:  2002-05-24       Impact factor: 5.226

View more
  2 in total

Review 1.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

2.  Tissue-specific human beta-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture system.

Authors:  Veronica Zaga-Clavellina; Martha Ruiz; Pilar Flores-Espinosa; Rodrigo Vega-Sanchez; Arturo Flores-Pliego; Guadalupe Estrada-Gutierrez; Irma Sosa-Gonzalez; Iyari Morales-Méndez; Mauricio Osorio-Caballero
Journal:  Reprod Biol Endocrinol       Date:  2012-09-03       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.